Cambridge Cognition Holdings PLC
LSE:COG
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
27.5
58
|
Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one COG stock under the Base Case scenario is 104.23 GBX. Compared to the current market price of 27.5 GBX, Cambridge Cognition Holdings PLC is Undervalued by 74%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Cambridge Cognition Holdings PLC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for COG cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Cambridge Cognition Holdings Plc is a neuroscience digital health company, which engages in the development of digital health products to better understand, detect, and treat conditions affecting brain health. The firm develops and markets digital solutions to assess brain health for sale worldwide, principally in the United Kingdom, the United States and Europe. Its products include CANTAB Recruit, CANTAB Connect, Cognition Kit, Cognition eCOA, CANTAB Connect Research, CANTAB Mobile, CANTAB BrainHealth, CANTAB Insight and NeuroVocalix. Its services include neuroscience consultancy, study design, data analysis, study management, data management plan, reporting and interpretation and technical consultancy. Its CANTAB Connect offers digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas. Its Cognition Kit is a custom-designed digital health platform delivering wearable and smartphone applications for high frequency data collection to demonstrate treatment efficacy and increase the understanding of a disease and a patient's response to medication.
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Cambridge Cognition Holdings PLC
Balance Sheet Decomposition
Cambridge Cognition Holdings PLC
Current Assets | 6.5m |
Cash & Short-Term Investments | 3.4m |
Receivables | 2.9m |
Other Current Assets | 188k |
Non-Current Assets | 7.5m |
Long-Term Investments | 156k |
PP&E | 68k |
Intangibles | 7.3m |
Other Non-Current Assets | 20k |
Current Liabilities | 10m |
Accounts Payable | 2.6m |
Other Current Liabilities | 7.4m |
Non-Current Liabilities | 1.5m |
Long-Term Debt | 1.5m |
Earnings Waterfall
Cambridge Cognition Holdings PLC
Revenue
|
13.1m
GBP
|
Cost of Revenue
|
-2.5m
GBP
|
Gross Profit
|
10.6m
GBP
|
Operating Expenses
|
-10.6m
GBP
|
Operating Income
|
-67k
GBP
|
Other Expenses
|
-1.3m
GBP
|
Net Income
|
-1.3m
GBP
|
Free Cash Flow Analysis
Cambridge Cognition Holdings PLC
GBP | |
Free Cash Flow | GBP |
COG Profitability Score
Profitability Due Diligence
Cambridge Cognition Holdings PLC's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Cambridge Cognition Holdings PLC's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
COG Solvency Score
Solvency Due Diligence
Cambridge Cognition Holdings PLC's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Score
Cambridge Cognition Holdings PLC's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
COG Price Targets Summary
Cambridge Cognition Holdings PLC
According to Wall Street analysts, the average 1-year price target for COG is 140.25 GBX with a low forecast of 126.25 GBX and a high forecast of 157.5 GBX.
Dividends
Current shareholder yield for COG is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one COG stock under the Base Case scenario is 104.23 GBX.
Compared to the current market price of 27.5 GBX, Cambridge Cognition Holdings PLC is Undervalued by 74%.